Regulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPases.
Three Rab GTPases, Rab1, Rab2 and Rab6, are involved in protein transport between the endoplasmic reticulum (ER) and the Golgi. Whereas Rab1 regulates the anterograde ER-to-Golgi transport, Rab2 and Rab6 coordinate the retrograde Golgi-to-ER transport. We have previously demonstrated that Rab1 differentially modulates the export trafficking of distinct G protein-coupled receptors (GPCRs). In this report, we determined the role of Rab2 and Rab6 in the cell-surface expression and signaling of alpha(2B)-adrenergic (alpha(2B)-AR), beta(2)-AR and angiotensin II type 1 receptors (AT1R). Expression of the GTP-bound mutant Rab2Q65L significantly attenuated the cell-surface expression of both alpha(2B)-AR and beta(2)-AR, whereas the GTP-bound mutant Rab6Q72L selectively inhibited the transport of beta(2)-AR, but not alpha(2B)-AR. Similar results were obtained by siRNA-mediated selective knockdown of endogenous Rab2 and Rab6. Consistently, Rab2Q65L and Rab2 siRNA inhibited alpha(2B)-AR and beta(2)-AR signaling measured as ERK1/2 activation and cAMP production, respectively, whereas Rab6Q72L and Rab6 siRNA reduced signaling of beta(2)-AR, but not alpha(2B)-AR. Similar to the beta(2)-AR, AT1R expression at the cell surface and AT1R-promoted inositol phosphate accumulation were inhibited by Rab6Q72L. Furthermore, the nucleotide-free mutant Rab6N126I selectively attenuated the cell-surface expression of beta(2)-AR and AT1R, but not alpha(2B)-AR. These data demonstrate that Rab2 and Rab6 differentially influence anterograde transport and signaling of GPCRs. These data also provide the first evidence indicating that Rab6-coordinated retrograde transport selectively modulates intracellular trafficking and signaling of GPCRs.
Dong
Chunmin
C
Department of Pharmacology and Experimental Therapeutics, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA.
Wu
Guangyu
G
D000818:Animals; D002460:Cell Line; D005799:Genes, Dominant; D005973:Glutamine / Q000235:genetics; D006801:Humans; D008239:Lysine / Q000235:genetics; D050505:Mutant Proteins / Q000378:metabolism; D021381:Protein Transport; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D015398:Signal Transduction; D013347:Subcellular Fractions / Q000378:metabolism; D020691:rab GTP-Binding Proteins / Q000378:metabolism*; D020693:rab2 GTP-Binding Protein / Q000378:metabolism*
D050505:Mutant Proteins; D034741:RNA, Small Interfering; C094135:Rab6 protein; D044140:Receptor, Angiotensin, Type 1; D018341:Receptors, Adrenergic, alpha-2; D018343:Receptors, Adrenergic, beta-2; D043562:Receptors, G-Protein-Coupled; D005973:Glutamine; D020691:rab GTP-Binding Proteins; D020693:rab2 GTP-Binding Protein; D008239:Lysine
J Biol Chem. 2003 Nov 21;278(47):47062-9
12970354
J Biol Chem. 2004 Mar 26;279(13):13110-8
14711821
J Cell Sci. 2004 Jul 1;117(Pt 15):3107-17
15190120
J Biol Chem. 2004 Jul 16;279(29):30741-50
15123661
J Biol Chem. 2004 Sep 24;279(39):41077-84
15252015
Biochem J. 1981 Jul 15;198(1):133-40
6275838
J Biol Chem. 1987 Oct 15;262(29):14282-8
2821000
J Biol Chem. 1990 Feb 5;265(4):1919-23
2153669
J Cell Biol. 1991 Oct;115(1):31-43
1918138
J Cell Biol. 1992 Nov;119(4):749-61
1429835
J Cell Biol. 1994 Dec;127(6 Pt 1):1575-88
7798313
J Biol Chem. 1996 Nov 15;271(46):29372-9
8910601
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1828-33
9050864
Biochim Biophys Acta. 1997 May 27;1356(3):281-91
9194571
J Biol Chem. 1997 Jul 11;272(28):17836-42
9211939
J Virol. 1997 Nov;71(11):8268-78
9343179
J Biol Chem. 1998 Mar 27;273(13):7197-200
9516410
J Mol Endocrinol. 1998 Jun;20(3):299-304
9687152
J Biol Chem. 1998 Aug 7;273(32):20425-30
9685396
Biochim Biophys Acta. 1998 Aug 14;1404(1-2):101-12
9714762
Mol Pharmacol. 1998 Sep;54(3):525-35
9730911
Pharmacol Ther. 1998 Dec;80(3):231-64
9888696
Mol Biol Cell. 1999 Jun;10(6):1837-49
10359600
Biochemistry. 1999 Jul 6;38(27):8621-7
10393537
Eur J Biochem. 1999 Jul;263(2):596-602
10406971
J Biol Chem. 2005 Jan 21;280(3):2300-8
15528211
Trends Pharmacol Sci. 2005 Mar;26(3):131-7
15749158
Cell Signal. 2005 Dec;17(12):1457-65
16014327
Cell Signal. 2006 Mar;18(3):318-27
15961277
J Biol Chem. 2006 Apr 21;281(16):11097-103
16484224
Mol Pharmacol. 2006 May;69(5):1571-8
16461589
J Cell Sci. 2006 Jun 1;119(Pt 11):2173-83
16723730
J Cell Biol. 1999 Nov 15;147(4):743-60
10562278
J Cell Biol. 2000 Feb 7;148(3):453-64
10662772
J Biol Chem. 2000 May 5;275(18):13727-36
10788493
Science. 2000 Jul 21;289(5478):444-8
10903204
J Biol Chem. 2000 Sep 1;275(35):27221-8
10854436
Mol Pharmacol. 2000 Oct;58(4):795-801
10999950
Annu Rev Physiol. 2001;63:607-30
11181969
Nat Cell Biol. 2001 May;3(5):492-8
11331877
J Biol Chem. 2002 Jan 4;277(1):679-85
11682489
J Biol Chem. 2002 Mar 29;277(13):11401-9
11799116
Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50
12209124
Receptors Channels. 2002;8(1):33-50
12402507
J Neurosci. 2002 Nov 15;22(22):9776-84
12427833
Blood. 2003 Mar 15;101(6):2115-24
12411301
Am J Physiol Cell Physiol. 2003 May;284(5):C1319-29
12540381
J Cell Sci. 2003 May 15;116(Pt 10):1969-80
12668728
Life Sci. 2003 Dec 5;74(2-3):217-24
14607249
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11821-7
16882731
J Biol Chem. 2006 Nov 10;281(45):34561-73
16959776
J Biol Chem. 2006 Dec 15;281(50):38543-54
17038316
Cell Signal. 2007 Mar;19(3):481-9
16979872
Biochim Biophys Acta. 2007 Apr;1768(4):853-70
17074298